The U.S. Commodity Futures Trading Commission (CFTC) has renewed its push to dismiss CME Group’s lawsuit over cryptocurrency perpetual futures, arguing that the derivatives exchange has failed to demonstrate concrete financial harm from the regulator’s policy.
In a court filing submitted on October 16, 2026, the CFTC reiterated that CME lacks the legal standing required to challenge the agency’s decision to allow certain cryptocurrency perpetual futures to be listed as futures contracts. The regulator argues that CME has not established an actual or imminent competitive injury and can list similar products itself if it chooses.
The dispute could have significant implications for the U.S. cryptocurrency derivatives market, particularly how perpetual futures are classified under federal law and which regulatory requirements apply to exchanges offering them.
The filing does not resolve the case. The court must still determine whether CME can pursue its challenge and, if the lawsuit proceeds, whether the CFTC’s regulatory approach is lawful.
CFTC Challenges CME Group’s Claim of Competitive Harm
The CFTC’s latest filing supports its earlier motion to dismiss CME’s lawsuit, which was filed in June 2026. The regulator contends that CME has not shown how the approval of competing perpetual futures products has caused measurable financial damage to its business.
According to the CFTC, CME remains free to introduce comparable contracts on its own designated contract market. The agency has also pointed to public statements from CME leadership indicating that the exchange’s core institutional customers have not expressed strong demand for these products.
The regulator has used CME’s own trading-volume figures to challenge its claims of competitive injury. The CFTC noted that trading volumes for several CME Bitcoin and Ether futures products were higher in June and August than in May, when the agency issued its order concerning Bitcoin perpetual futures.
The CFTC argues that this data undermines the assertion that its policy has already harmed CME’s business.
However, higher trading volumes in selected products do not, by themselves, settle the question of whether the policy has created a competitive disadvantage. The court will need to evaluate the parties’ legal arguments and the evidence presented in the case.
Why CME Is Challenging the CFTC’s Perpetual Futures Policy
CME Group’s lawsuit stems from the CFTC’s May 29, 2026, order approving Kalshi’s Bitcoin perpetual futures contract, alongside a broader policy statement concerning the listing of similar contracts.
CME argues that cryptocurrency perpetual contracts should be classified as swaps rather than futures under the Commodity Exchange Act and the Dodd-Frank Act. The exchange also alleges that the CFTC changed its regulatory position without adequately addressing the relevant statutory framework and procedural requirements.
CME filed its lawsuit on June 18, seeking to overturn the agency’s order and challenge its broader approach to perpetual futures.
The exchange says the policy allows competing platforms to offer products that target some of the same retail customers as CME under a different regulatory classification. In its complaint, CME characterized this as a competitive injury and argued that the CFTC’s actions were unlawful.
The CFTC disputes that interpretation. It argues that the exchange has not demonstrated the type of injury necessary to bring the case and that its claims do not justify judicial intervention.
The disagreement therefore involves two separate questions: whether CME has legal standing to sue and whether the regulator correctly classified the products under federal derivatives law.
What Are Cryptocurrency Perpetual Futures?
Perpetual futures, often called “perps,” are derivatives that allow traders to take positions on an asset’s price without owning the underlying cryptocurrency directly.
Unlike traditional futures contracts, perpetual futures do not have a fixed expiration date. Instead, they typically use a funding-rate mechanism through which traders holding long or short positions make periodic payments to one another. This mechanism is designed to help keep the contract’s price aligned with the underlying asset’s spot price.
Perpetual contracts have become widely used in cryptocurrency markets, particularly on offshore trading platforms. Their introduction to U.S.-regulated venues has drawn attention because the products combine a popular crypto-market structure with the compliance requirements applicable to domestic derivatives exchanges.
The legal classification matters because futures and swaps can be subject to different regulatory requirements, trading structures and tax treatment. The precise consequences depend on the product and the applicable rules.
For regulators, the challenge is to determine how existing legislation applies to these products. For exchanges, the classification can affect how contracts are listed, supervised and marketed to customers.
CFTC Argues the Lawsuit Could Restrict Competition
Beyond disputing CME’s claims of financial harm, the CFTC has argued that the lawsuit conflicts with the Commodity Exchange Act’s broader objectives of market integrity, self-regulation and fair competition among exchanges.
The regulator maintains that allowing designated contract markets to introduce new products under the applicable statutory framework supports responsible innovation. It argues that CME should not be able to use litigation to prevent competitors from offering products that CME itself could choose to list.
The agency has also contended that changing the classification of perpetual futures would not necessarily eliminate the competitive pressure CME describes. Other registered exchanges could potentially continue offering comparable products under a different regulatory framework.
This argument places competition and regulatory consistency at the center of the case. The CFTC says the law should not be interpreted in a way that gives an incumbent exchange the ability to block new products simply because they compete with its existing business.
CME’s position is different: it argues that the issue is not merely competition, but whether the CFTC followed federal law when it approved the contracts and adopted its policy.
The Court Must Decide Whether CME Has Standing
The legal standing question is an important early hurdle in the case.
Under U.S. law, a plaintiff generally must demonstrate a sufficiently concrete injury that is connected to the challenged conduct and could be addressed by a favorable court decision. A company’s disagreement with a regulator is not, on its own, enough to establish standing.
The CFTC argues that CME has failed to meet this standard because it has not shown a plausible financial injury resulting from the agency’s actions. It also disputes whether the relief CME seeks would resolve the alleged competitive harm.
If the court dismisses the lawsuit on standing or other threshold grounds, it may not need to reach the underlying dispute over whether perpetual futures should be classified as futures or swaps.
If the case proceeds, the court could examine CME’s statutory arguments, the agency’s reasoning and the procedures used to approve the products.
As of October 20, 2026, the court has not issued a final ruling resolving the dispute. The CFTC’s October 16 filing is part of the ongoing briefing process, not a judicial determination that CME lacks standing.
What the Case Could Mean for U.S. Crypto Derivatives
The outcome could influence how cryptocurrency derivatives are offered through U.S.-regulated exchanges.
If the CFTC’s approach survives the legal challenge, exchanges may have a clearer path to listing certain perpetual futures under the framework established by the agency. That could increase competition among regulated venues and broaden the range of derivatives products available to eligible U.S. customers.
If CME succeeds, the ruling could require the CFTC to reconsider aspects of its classification or approval process. Depending on the court’s reasoning, the decision could also affect how regulators approach future products that combine features of traditional futures and cryptocurrency perpetual contracts.
The case may therefore extend beyond the immediate interests of CME and the CFTC. Exchanges, crypto trading platforms, market makers and institutional investors will be watching for clarity on the regulatory treatment of perpetual derivatives.
However, the ultimate effect will depend on the court’s decision and any subsequent regulatory or legislative developments. The current filings do not establish that all perpetual futures will be treated identically or that the ruling will automatically determine the status of every crypto derivative.
Bottom Line
The CFTC is asking the court to dismiss CME Group’s challenge to the agency’s cryptocurrency perpetual futures policy, arguing that the exchange has not demonstrated concrete financial harm and can offer similar products itself.
CME maintains that the CFTC improperly classified perpetual contracts and created an uneven competitive environment for derivatives exchanges. The court has yet to resolve the dispute.
The case is an important test of how U.S. regulators classify cryptocurrency derivatives and how much evidence an incumbent exchange must provide to challenge a regulator’s decision on competitive grounds. Until the court rules, the legal status of the dispute remains unresolved.
Disclaimer: This article is for informational purposes only and does not constitute legal, financial or investment advice. The court proceedings remain ongoing, and the parties’ arguments should not be interpreted as a final judicial ruling.
Also Check: SEC Closes Public Comment Period on Crypto Rules After About 140 Submissions
